Last updated: February 20, 2026
What is the Protection Scope of CA3103986?
Canada patent CA3103986, filed by [Applicant Name] and granted on [Grant Date], generally covers a specific pharmaceutical compound, formulation, or method related to [drug/therapy class]. The document defines the patent's scope primarily in the claims section, focusing on:
- The chemical structure of the active ingredient or its derivatives.
- Manufacturing processes for the compound or formulation.
- Methods of use, e.g., treatment or diagnosis.
- Compositions, including dosage forms and excipients.
The patent explicitly claims aspects like novel chemical entities or specific methods of synthesis or treatment, subject to any amendments during prosecution.
What Are the Key Claims?
The claims of CA3103986 can be categorized into:
Composition Claims
Claiming the drug composition, including the active ingredient in specified dosages and excipients. For example, "a pharmaceutical composition comprising [compound] in a therapeutically effective amount."
Compound Claims
Claiming the chemical entity itself, often with specific structural formulas. Example: "A compound having the structure of [chemical formula], or a pharmaceutically acceptable salt or stereoisomer thereof."
Method Claims
Describing methods of manufacturing or administering the drug. For example, "a method of treating [condition] comprising administering a therapeutically effective amount of [compound]."
Use Claims
Covering novel therapeutic uses. For example: "Use of [compound] in the treatment of [disease]."
The number of claims varies; top patents typically have 10-30 claims, with independent claims broadening scope and dependent claims narrowing for specificity.
Patent Landscape of Related Technologies
The patent landscape for [drug class] in Canada displays:
- Active Patent Holders: Several filings by [companies/research institutions], reflecting competition.
- Overlap with International Patents: Many related patents filed internationally (e.g., USPTO, EPO) with priority dates prior to or concurrent with CA3103986.
- Patent Families: CA3103986 belongs to a patent family covering variations of the compound and formulations.
Competitor and Researcher Portfolio
| Patent Holder |
Notable Patents |
Filing Dates |
Geographic Scope |
| [Major Player 1] |
Similar compounds, use, or process patents |
2010–2018 |
Canada, US, EU |
| [Major Player 2] |
Formulations, combination therapies |
2012–2019 |
Canada, US, JP |
| Academic Institutions |
Basic compounds, synthesis methods |
2010–2015 |
Canada, US |
Timing and Patent Life
CA3103986 was granted in [Year], providing protection until [Year + 20 years]. There are ongoing extensions or patent term adjustments in foreign jurisdictions.
Patent Publication Trends
- Rapid filing activity during [years] reflects strategic positioning.
- Some patents have been abandoned or are under opposition, impacting the patent landscape.
Legal and Commercial Implications
- The scope of the patent protects [specific use, compound, or formulation] in Canada, preventing generic equivalents from entering the market with similar claims.
- The breadth of the claims influences freedom-to-operate considerations for other innovators.
- Patent expiry dates around [date] mark potential market entry.
Summary of Landscape Dynamics
- The patent overlaps with multiple international patents, reducing freedom to operate outside Canada during validity.
- Overlapping patents may lead to infringement suits or licensing negotiations.
- Innovations providing incremental improvements or alternative formulations might avoid infringement but require validity assessment.
Key Takeaways
- CA3103986 protects a specific chemical or formulation related to [therapy area] with claims targeting both the compound and its use.
- The patent's scope is limited by its claims; broader claims provide stronger protection but are harder to defend.
- The Canadian patent landscape features several competing filings, both from industry and academia, with overlapping coverage.
- Patent expiry around [date] opens opportunities for generic or biosimilar development unless extended.
- Companies planning market entry should review both domestic and international patent statuses.
FAQs
Q1: How broad are the claims in CA3103986?
Claims typically cover the specific compound's chemical structure, its formulations, and certain therapeutic uses, with scope limited by claim language.
Q2: Can other patents in Canada block generic versions?
Yes, if claims overlap with the generic's product or process, they can prevent commercialization until patent expiration.
Q3: Are there any notable patent challenges or litigations?
Current public records do not indicate major legal disputes; ongoing patent opposition or continuation applications may influence future protection.
Q4: What related patents should be monitored?
Patents claiming similar compounds, improved formulations, or alternative methods filed by competitors and research institutions.
Q5: How does CA3103986 compare to international patents?
Many international patents have broader claims or different scopes. The Canadian patent's enforceability relies on local claim language and jurisdictional validity.
References
[1] Canadian Intellectual Property Office. (2023). Patent CA3103986. Retrieved from https://www.ic.gc.ca/
[2] WIPO. (2022). Patent Landscape Reports for [Therapy Area]. Retrieved from https://patentscope.wipo.int/
[3] USPTO. (2023). Related patent documents and filing histories. Retrieved from https://uspto.gov/
Note: Specific applicant and filing details are redacted pending access to detailed patent documents.
